INTERNATIONAL PATENT: SCINNOHUB PHARMACEUTICAL CO., LTD, 赛诺哈勃药业（成都）有限公司 FILES APPLICATION FOR "BIAZACYCLOALKANE MENIN-MLL PROTEIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF"

GENEVA, May 18 -- SCINNOHUB PHARMACEUTICAL CO., LTD (No. 263, Hexiang 3rd Street, High-tech ZoneChengdu, Sichuan 610094), 赛诺哈勃药业（成都）有限公司 (中国四川省成都市高新区和祥三街263号) filed a patent application (PCT/CN2025/133759) for "BIAZACYCLOALKANE MENIN-MLL PROTEIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF" on Nov 10, 2025. With publication no. WO/2026/098672, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) ...